2021
DOI: 10.1039/d1cc03743a
|View full text |Cite
|
Sign up to set email alerts
|

CRISPR/Cas12a-mediated liposome-amplified strategy for the photoelectrochemical detection of nucleic acid

Abstract: This work reports a photoelectrochemical biosensor for dopamine-loaded liposome-encoded magnetic beads cleaved by clustered regularly interspaced short palindromic repeats (CRISPR)/Cas 12a system for quantification of human papillomavirus (HPV)-related DNA by...

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
47
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 96 publications
(47 citation statements)
references
References 23 publications
0
47
0
Order By: Relevance
“…Recently, CRISPR-Cas has emerged as a powerful technology that is revolutionizing next-generation diagnostic platforms [6] , [7] . The mechanism of CRISPR-Cas systems, which are programmed by CRISPR guide RNA (crRNA), has been reported to not only cleave the target nucleic acid but also cleave all neighbouring nucleic acids indiscriminately [8] , [9] . This target-triggered collateral activity of CRISPR-Cas systems has stimulated the development of CRISPR-based biosensing technologies [10] , [11] , which offer unique advantages of simple fabrication, ultrahigh sensitivity, high specificity to single-base variation, and good amenability for POC diagnostics [12] , [13] , [14] .…”
Section: Introductionmentioning
confidence: 99%
“…Recently, CRISPR-Cas has emerged as a powerful technology that is revolutionizing next-generation diagnostic platforms [6] , [7] . The mechanism of CRISPR-Cas systems, which are programmed by CRISPR guide RNA (crRNA), has been reported to not only cleave the target nucleic acid but also cleave all neighbouring nucleic acids indiscriminately [8] , [9] . This target-triggered collateral activity of CRISPR-Cas systems has stimulated the development of CRISPR-based biosensing technologies [10] , [11] , which offer unique advantages of simple fabrication, ultrahigh sensitivity, high specificity to single-base variation, and good amenability for POC diagnostics [12] , [13] , [14] .…”
Section: Introductionmentioning
confidence: 99%
“…10,11 Furthermore, diagnostic technologies based on the CRISPR-associated nuclease (Cas) system have also been developed rapidly. [12][13][14][15] The CRISPR-Cas system has many notable advantages, like mild reaction temperature, fast reaction time, excellent specificity, and highefficiency signal amplification capabilities. These features make it a powerful next-generation diagnostic technology.…”
mentioning
confidence: 99%
“…21,22 Afterward, newer methods were introduced by utilizing the sequence-nonspecific collateral cleavage activity found in Cas12 and Cas13 proteins that has facilitated the development of numerous diagnostic tools for rapid and portable detection, consequently yielding great potential for point of care settings. 23–26 Beyond nucleic acid detection, 27–29 Cas12a is being recently exploited to construct novel strategies for the detection of various biological analytes such as small molecules, 30 lipopolysaccharide, 31 transcription factors, 32 and enzyme activities 33 due to its exceptional capability for signal amplification by cleaving nearby ssDNA reporter upon target DNA recognition.…”
mentioning
confidence: 99%